ResearcherQingdao UniversityActive in the last 2 years

Yueyi Xing

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6308-0640; OpenAlex author ID A5016707797. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Elevated serum lipoprotein(a) as a prognostic marker for reduced survival in pancreatic cancer. Co-author DOI 10.1186/s12876-025-04573-9 ↗
Correlation of laminin subunit alpha 3 expression in pancreatic ductal adenocarcinoma with tumor liver metastasis and survival. Co-author DOI 10.2478/raon-2024-0020 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xue Jing · 2 shared papers, 2024–2025 · strength 0.58
- Paper Correlation of laminin subunit alpha 3 expression in pancreatic ductal adenocarcinoma with tumor liver metastasis and s… DOI 10.2478/raon-2024-0020 ↗
- Paper Elevated serum lipoprotein(a) as a prognostic marker for reduced survival in pancreatic cancer. DOI 10.1186/s12876-025-04573-9 ↗
Yueping Jiang · 1 shared paper, 2024 · strength 0.31
- Paper Correlation of laminin subunit alpha 3 expression in pancreatic ductal adenocarcinoma with tumor liver metastasis and s… DOI 10.2478/raon-2024-0020 ↗
J H Liu · 1 shared paper, 2025 · strength 0.27
- Paper Elevated serum lipoprotein(a) as a prognostic marker for reduced survival in pancreatic cancer. DOI 10.1186/s12876-025-04573-9 ↗
Libin Liu · 1 shared paper, 2025 · strength 0.27
- Paper Elevated serum lipoprotein(a) as a prognostic marker for reduced survival in pancreatic cancer. DOI 10.1186/s12876-025-04573-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.